Valuation (31%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 31.85 | 18.82 |
| PEG Ratio (TTM) | -1.06 | -0.07 |
| P/S Ratio (TTM) | 0.18 | 0.55 |
| P/B Ratio (TTM) | 2.54 | 1.40 |
| P/FCF Ratio (TTM) | 22.39 | 13.50 |
| Price to 5YR AVG Earnings Ratio | N/A | 15.48 |
| Price to 5YR AVG FCF Ratio | N/A | 62.46 |
Profitability (15%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.74% | 4.37% |
| ROE (TTM) | 8.99% | 9.38% |
| Net Profit Margin (TTM) | 0.58% | 1.13% |
| ROIC 5YR AVG | N/A | 12.07% |
Growth (35%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -15.71% | 287.02% | N/A |
| Revenue | -3.88% | 7.56% | N/A |
| Net Income | -15.81% | 284.14% | N/A |
| Cash Flow | 409.49% | 13.88% | N/A |
Health (49%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.21 | 1.99 |
| Quick Ratio (TTM) | 1.19 | 1.18 |
| D/E Ratio (TTM) | 0.05 | 0.52 |
| Interest Coverage (TTM) | 10.61 | 4.33 |
| Piotroski F-Score | 5 | 7 |
| Altman Z-Score | 11.57 | 3.93 |
| LTL to 5YR AVG FCF | N/A | 18.32 |
| Shares Outstanding Growth 5YR AVG | N/A | 0.90% |